Characteristics and Impact of Drug Detailing for Gabapentin

• Michael A Steinman ,

  *To whom correspondence should be addressed. E-mail: mike.steinman@ucsf.edu

  Affiliations San Francisco Veterans Affairs Medical Center, San Francisco, California, United States of America , Division of Geriatrics, University of California, San Francisco, California, United States of America

  ⨯
• G. Michael Harper,

  Affiliations San Francisco Veterans Affairs Medical Center, San Francisco, California, United States of America , Division of Geriatrics, University of California, San Francisco, California, United States of America

  ⨯
• Mary-Margaret Chren,

  Affiliations San Francisco Veterans Affairs Medical Center, San Francisco, California, United States of America , Department of Dermatology, University of California, San Francisco, California, United States of America

  ⨯
• C. Seth Landefeld,

  Affiliations San Francisco Veterans Affairs Medical Center, San Francisco, California, United States of America , Division of Geriatrics, University of California, San Francisco, California, United States of America

  ⨯
• Lisa A Bero

  Affiliations Department of Clinical Pharmacy, University of California, San Francisco, California, United States of America , Institute for Health Policy Studies, University of California, San Francisco, California, United States of America

  ⨯